Immucillin derivative
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immucillin derivative, covering 2017-09-26 to 2017-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis [Phase 2]